Avalon globocare announces collaboration with the university of pittsburgh medical center hillman cancer center to advance clinical development of cellular immunotherapies using the flash-car™ platform

Freehold, n.j., march 29, 2021 (globe newswire) -- avalon globocare corp. (nasdaq: avco) (avalon or the company), a clinical-stage global developer of cell-based technologies and therapeutics, today announces entering into a collaboration agreement with the university of pittsburgh medical center (upmc) hillman cancer center to advance the clinical development and production of avalon's next-generation, chimeric antigen receptor (car) therapies using flash car™ technology.
AVCO Ratings Summary
AVCO Quant Ranking